Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2022-10-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第三季度报告' which translates to '2022 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on shareholder information. The report covers the third quarter of 2022, providing comprehensive financial performance and operational data for that period. It explicitly states that the financial statements are unaudited for the quarter. The length of the document (over 12,000 characters) and the presence of substantive financial data confirm it is a full quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-10-28 Chinese
益丰药房关于变更注册资本及修订《公司章程》的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding changes in the company's registered capital and corresponding amendments to the company's articles of association (公司章程). It details share capital changes due to stock incentive plan adjustments and the resulting updates to the company's registered capital and share count. The document also mentions that these changes will be submitted to the shareholders' meeting for approval and that the articles of association will be revised accordingly. There is no financial report, earnings data, or detailed financial statements included. The document is a formal announcement of capital changes and governance document amendments, which fits the category of Share Issue/Capital Change (SHA). The document length is short (1051 characters), and it is not merely an announcement of a report publication but a substantive announcement of capital changes and articles amendment.
2022-10-28 Chinese
《公司章程》（2022年10月修订）
Governance Information Classification · 100% confidence The document is titled "益丰大药房连锁股份有限公司 公司章程" which translates to "Yifeng Pharmacy Chain Co., Ltd. Articles of Association" or "Company Bylaws." The content includes detailed provisions on company organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive internal governance document that sets out the rules and regulations for the company's operation and management. There is no indication that this is a report of financial results, audit, or an announcement. It is not a proxy statement or voting results announcement, nor is it a presentation or call transcript. The document fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-10-28 Chinese
益丰药房2022年第五次临时股东大会通知
Regulatory Filings Classification · 95% confidence The document is a notice about convening the 2022 fifth extraordinary general meeting of shareholders (临时股东大会) for Yifeng Pharmacy Chain Co., Ltd. It includes details about the meeting date, voting methods, agenda items, and instructions for shareholders. There is no financial data or report content, only an announcement of the meeting and related procedural information. The document length is 2887 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a shareholder meeting and does not fit other more specific categories like AGM Information or Declaration of Voting Results, as it does not contain the actual meeting materials or voting results.
2022-10-28 Chinese
益丰药房关于2022年第三季度主要经营数据的公告
Interim / Quarterly Report Classification · 95% confidence The document is titled as an announcement regarding the main operating data for the third quarter of 2022 for Yifeng Pharmacy Chain Co., Ltd. It contains detailed financial and operational data for the quarter, including revenue, profit, assets, and store expansion information. The data is specific to a quarterly period (2022 Q3) and includes substantive financial figures and analysis. The document length is 2777 characters, which is relatively short but contains actual financial data rather than just a notice or link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR) rather than a brief announcement or a full annual report. It is not a simple publication announcement or certification, but a substantive quarterly operating data disclosure as required by the Shanghai Stock Exchange guidelines referenced in the text. 9M 2022
2022-10-28 Chinese
益丰药房第四届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 20th meeting of the 4th Board of Directors of Yifeng Pharmacy Chain Co., Ltd. It includes details about the meeting attendance, voting results, and decisions made, such as approval of the 2022 Q3 report, changes in registered capital, and plans to convene an extraordinary general meeting. The document does not contain the full quarterly report or detailed financial statements but references where the full report can be found. It is primarily a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1515 characters), and it is not the report itself but an announcement of board decisions.
2022-10-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.